comprehensive -WSS

comprehensive

author：hotspot 2025-09-06 03:26:11 - browse：82387

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： AstraZeneca stays mum on Medicare drug pricing negotiations

knowledge

WSS

STAT Readout Newsletter: Today's biggest biotech updates

The Biogen Aduhelm mess could happen again

NIH confirmation hearing shows politicization of research

Eli Lilly expects to double planned employment in Boston center

What’s missing from the debate over nursing home staff minimums

2023 STAT Wunderkinds: get to know the winners

hotspot

comprehensive

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Impact of Dobbs ruling felt at reproductive medicine meeting

Sports medicine is finally prioritizing gender equality

Impact of Dobbs ruling felt at reproductive medicine meeting

Sports medicine is finally prioritizing gender equality

FDA warns J&J's Abiomed: We will regulate your software

Alkermes shareholders re

Medicare reduced heart disease by changing how it pays doctors

After affirmative action ruling, medical educators look to 'holistic review'

Why CTE doesn’t keep Americans from enjoying the Super Bowl

focus

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Texas Medical Board asked to define abortion emergency exception

Pharmacists can make shortage drugs, but at what cost?

Why Novartis is going to walk from its acquisition of MorphoSys

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Wikipedia

knowledge

hotspot

hotspot